← Back
Data updated: Mar 29, 2026
MICRO LABS
CardiovascularNeurologyImmunology
Generics
MICRO LABS is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology. Key products include LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE.
1988
Since
82
Drugs
-
Trials
887
Approved (2yr)
Key Drugs
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium
COX-1 4 indications · 2012
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
chlordiazepoxide hydrochloride
4 indications · 2020
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
amlodipine besylate
AT1 receptor 3 indications · 2016
FENOFIBRIC ACID
choline fenofibrate
PPAR alpha 2 indications · 2013
LOPINAVIR AND RITONAVIR
lopinavir
CYP3A 1 indications · 2016
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 38%
11 drugs
Neurology 21%
6 drugs
Immunology 14%
4 drugs
Respiratory 14%
4 drugs
Infectious Disease 14%
4 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
GSK big-pharma
Infectious Disease, Respiratory, Immunology, Neurology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
AbbVie big-pharma
Immunology, Neurology, Infectious Disease
Active (50)
BRIVARACETAM VARENICLINE TARTRATE ARFORMOTEROL TARTRATE FORMOTEROL FUMARATE CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE TAFLUPROST CARBOPROST TROMETHAMINE SAPROPTERIN DIHYDROCHLORIDE ROFLUMILAST DALFAMPRIDINE LOPINAVIR AND RITONAVIR OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL COLCHICINE RUFINAMIDE TENOFOVIR DISOPROXIL FUMARATE CELECOXIB TELMISARTAN RANOLAZINE RAMELTEON RASAGILINE MESYLATE FENOFIBRIC ACID DICLOFENAC SODIUM AND MISOPROSTOL LAMIVUDINE TRANEXAMIC ACID MEFENAMIC ACID ASPIRIN AND DIPYRIDAMOLE LEVETIRACETAM DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE CAFFEINE CITRATE SIMVASTATIN METOLAZONE METHENAMINE HIPPURATE BRIMONIDINE TARTRATE AMOXICILLIN AND CLAVULANATE POTASSIUM FAMOTIDINE NICARDIPINE HYDROCHLORIDE CLOMIPRAMINE HYDROCHLORIDE DICLOFENAC SODIUM CROMOLYN SODIUM TOBRAMYCIN CLINDAMYCIN HYDROCHLORIDE TIMOLOL MALEATE BACLOFEN ERYTHRA-DERM VERAPAMIL HYDROCHLORIDE PROPARACAINE HYDROCHLORIDE SUCCINYLCHOLINE CHLORIDE DOXEPIN HYDROCHLORIDE
Discontinued (25)
BUPROPION HYDROCHLORIDE TOFACITINIB CITRATE LOSARTAN POTASSIUM FLUOXETINE HYDROCHLORIDE FUROSEMIDE ISOPROTERENOL HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE SEVELAMER CARBONATE TRIAMCINOLONE ACETONIDE AMOXICILLIN PIROXICAM PIRFENIDONE DEXAMETHASONE SODIUM PHOSPHATE NEVIRAPINE CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE AND OLMESARTAN MEDOXOMIL GLIMEPIRIDE CLOBAZAM MIDAZOLAM HYDROCHLORIDE LIFITEGRAST MISOPROSTOL LINCOMYCIN HYDROCHLORIDE SODIUM NITROPRUSSIDE LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
Company Info
- First Approval
- 1988-02-05
- Latest
- 2026-02-23
- Applications
- 97
FDA Sponsor Names
MICRO LABSMICRO LABS LTD